Department of Health and Human Services January 2010 – Federal Register Recent Federal Regulation Documents
Results 251 - 267 of 267
Medical Device Quality System Regulation Educational Forum on Risk Management Through the Product Life Cycle; Public Workshop
The Food and Drug Administration (FDA), Office of Regulatory Affairs (ORA), Southwest Region (SWR), Dallas District Office (DALDO), in collaboration with the FDA Medical Device Industry Coalition (FMDIC), is announcing a public workshop entitled ``Medical Device Quality System Regulation Educational Forum on Risk Management through the Product Life Cycle.'' This public workshop is intended to provide information about FDA's Medical Device Quality Systems Regulation (QSR) to the regulated industry, particularly small businesses.
Event Problem Codes Web Site; Center for Devices and Radiological Health; Availability
The Food and Drug Administration (FDA) is announcing the availability of a Web site where the Center for Devices and Radiological Health (CDRH) is posting updates to the problem codes used in conjunction with the medical device adverse event reports (MDR) regulation.
Canned Pacific Salmon Deviating From Identity Standard; Extension of Temporary Permit for Market Testing
The Food and Drug Administration (FDA) is announcing the extension of a temporary permit issued to Yardarm Knot Fisheries, LLC, to market test products designated as ``skinless and boneless sockeye salmon'' that deviate from the U.S. standard of identity for canned Pacific salmon. The extension will allow the permit holder to continue to collect data on consumer acceptance of the product while the agency takes action on a petition to amend the standard of identity for canned Pacific salmon that was submitted by Yardarm Knot Fisheries, LLC.
Memorandum of Understanding Between the United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Northeastern University
The Food and Drug Administration (FDA) is providing notice of a Memorandum of Understanding (MOU) between FDA and Northeastern University. The purpose of the MOU is to form a collaborative relationship between FDA and Northeastern University; provide opportunities for exchanging of graduate and undergraduate students, faculty, and personnel and for advanced training and outreach; stimulate cooperative research, and information exchange in biological product characterization and regulation with Northeastern University's Barnett Institute of Chemical and Biological Analysis; and develop training programs for FDA and potentially other Government agencies and Industry in the broad areas of biotechnology and analytical chemistry.
Office of the Assistant Secretary for Administration; Statement of Organization, Functions, and Delegations of Authority
The Department of Health and Human Services (HHS) is reorganizing the Office of the Assistant Secretary for Administration (ASA) located within the Office of the Secretary (OS). The reorganization is designed to increase the efficiency and effectiveness of the office by consolidating the administrative functions under ASA. The Office of the Secretary Executive Office will also be dissolved, and the administrative functions will be consolidated with similar functions already performed by existing offices within OS.
Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories currently certified to meet the standards of Subpart C of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on April 13, 2004 (69 FR 19644).
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
